Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the most prevalent, with a worldwide prevalence estimated at 12%. IBS is an important health care concern as it greatly affects patients’ quality of life and imposes a significant economic burden to the health care system. Cardinal symptoms of IBS include abdominal pain and altered bowel habits. The absence of abdominal pain makes the diagnosis of IBS untenable. The diagnosis of IBS can be made by performing a careful review of the patient’s symptoms, taking a thoughtful history (e.g., diet, medication, medical, surgical, and psychological history), evaluating the patient for the presence of warning signs (e.g., “red flags” of anemia, hematochezia, unintentional weight loss, or a family history of colorectal cancer or inflammatory bowel disease), performing a guided physical examination, and using the Rome IV criteria. The Rome criteria were developed by a panel of international experts in the field of functional gastrointestinal disorders. Although initially developed to guide researchers, these criteria have undergone several revisions with the intent of making them clinically useful and relevant. This monograph provides a brief overview on the development of the Rome criteria, discusses the utility of the Rome IV criteria, and reviews how the criteria can be applied clinically to diagnose IBS. In addition, a diagnostic strategy for the cost-effective diagnosis of IBS will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the diagnostic criteria for functional somatic disorders usually do not require that the symptoms cause distress”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the Rome IV criteria for irritable bowel syndrome describe only clear patterns of abdominal pain and altered bowel habits”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 3×
“Bristol stool types 1 and 2 or types 6 and 7 are considered abnormal [12].”
BackgroundMethodInfluentialLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citationFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“The revised Rome II criteria were published in 1999 [5].”
MethodTowards positive diagnosis of the irritable bowel.
Manning, A. P., Thompson, W. G., Heaton, K. W., & Morris, A. F. (1978) · BMJ · doi:10.1136/bmj.2.6138.653 · Cited by 1,374
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.014 · Cited by 719
Ford, A. C., Lacy, B. E., & Talley, N. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1607547 · Cited by 587
Self-citationLagattolla, N. (2002) · Key Topics in General Surgery · doi:10.1201/b14719-46 · Cited by 521
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“The diagnostic accuracy of the Rome I criteria was evaluated in a study of 339 IBS patients with a reported sensitivity of 85% and a specificity of 71% [4].”
MethodFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405 · cited 1×
“This should improve visceral pain and may slow colonic transit to some degree [19].”
BackgroundSelf-citation
Cited by
Items 101–200 of 582
Multilocus genotyping of Giardia duodenalis from pigs in Korea
Lee, H., Jung, B.-Y., Lim, J., Seo, M.-G., Lee, S., Choi, K. H., Hwang, M.-H., Kim, T., Kwon, O., & Kwak, D. (2020) · Parasitology International · doi:10.1016/j.parint.2020.102154 · Cited by 24
Waqar, S. H. B., & Rehan, A. (2019) · Cureus · doi:10.7759/cureus.4764 · Cited by 28
Biomarkers in Irritable Bowel Syndrome: Biological Rationale and Diagnostic Value
Nakov, R., Snegarova, V., Dimitrova‐Yurukova, D., & Velikova, T. V. (2021) · Digestive Diseases · doi:10.1159/000516027 · Cited by 32
Pimentel, M., Mathur, R., Wang, J., Chang, C. S., Hosseini, A., Fiorentino, A., Rashid, M. A., Pichetshote, N., Basseri, B., Treyzon, L., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001723 · Cited by 26
Jung, K.-M., Kim, A., Lee, J., Cho, D., Seo, J., Jung, E. S., Kang, H., Roh, J., & Kim, W.-G. (2022) · Nutrients · doi:10.3390/nu14102015 · Cited by 28
Nardo, G. D., Barbara, G., Borrelli, O., Cremon, C., Giorgio, V., Greco, L., Pietra, M. L., Marasco, G., Pensabene, L., Piccirillo, M., et al. (2024) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-024-01607-y · Cited by 36
“Patients with IBS-M have > 25% of their bowel movements associated with stool types 1 or 2 and > 25% of their bowel movements associated with stool types 6 or 7 [29].”
BackgroundExploring the Genetic Diversity of the 16S rRNA Gene of Akkermansia Muciniphila in IBD and IBS
Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Cella, E., Putignani, L., Guarino, M. P. L., Monteleone, G., Cicala, M., Angeletti, S., et al. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0175 · Cited by 27
Sharawy, S. M. E., Amer, I. F., & Elkadeem, M. Z. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.41.311.28228 · Cited by 31
“At present, the Rome III criteria are the main method for IBS diagnosis without the need for any biochemical markers, provided that warning signs have to be excluded [3, 4].”
MethodHüsing, P., Smakowski, A., Löwe, B., Kleinstäuber, M., Toussaint, A. C., & Mora, M. C. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1142484 · Cited by 32
“, irritable bowel syndrome (19), fibromyalgia (20) and chronic fatigue syndrome (21), do not contain any psychological factors at all.”
BackgroundFurgała, A., Ciesielczyk, K., Przybylska-Feluś, M., Jabłoński, K., Gil, K., & Zwolinska-Wcislo, M. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-36445-1 · Cited by 35
Chang, K., Lee, M., Lin, H., Wu, S.-L., & Wu, H. (2021) · International Urogynecology Journal · doi:10.1007/s00192-021-04711-3 · Cited by 23
“In Taiwan, the Rome criteria, which have undergone several revisions, are generally used for the diagnosis of IBS [11].”
MethodEthnic differences in genetic polymorphism associated with irritable bowel syndrome
Xiao, Q.-Y., Fang, X., Li, X., & Fei, G. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i17.2049 · Cited by 26
Transeth, E. L., Dale, H. F., & Lied, G. A. (2020) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2020.19551 · Cited by 24
“(Continue) Diagnosis First author, year of publication Study design Participants (n) Specimen Method of detection Main findings Chung (31) 2015 Case-control IBS (28) Control (19) Fecal sample Jejunal biopsy 16s rRNA sequencing PCR Fecal samples ↑ Firmicutes/Bacteroidetes ratio in IBS-D ↑ Veillonellaceae (Firmicutes) i…”
BackgroundDoes Alzheimer's disease stem in the gastrointestinal system?
Khodabakhsh, P., Bazrgar, M., Dargahi, L., Mohagheghi, F., Taei, A. A., Parvardeh, S., & Ahmadiani, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120088 · Cited by 23
Horn, A., Stangl, S., Parisi, S., Bauer, N., Roll, J., Löffler, C., Gágyor, I., Haas, K., Heuschmann, P. U., Langhorst, J., et al. (2023) · Stress and Health · doi:10.1002/smi.3226 · Cited by 22
Developing the FIGO ‐ IPPS “R U MOVVING SOMe ” classification system for female chronic pelvic pain
Lamvu, G., Villegas‐Echeverri, J. D., Allaire, C., As‐Sanie, S., Carrillo, J. F., Khalil, S., Horne, A. W., Wang, A., & Munro, M. G. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70522 · Cited by 26
“62,64,65 These criteria classify IBS into subtypes: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), and IBS with mixed bowel habits (IBS-M).”
Owusu, J. T., Sibelli, A., Moss-Morris, R. E., van Tilburg, M. A. L., Levy, R. L., & Oser, M. L. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14108 · Cited by 23
Non-Celiac Gluten Sensitivity and Irritable Bowel Disease: Looking for the Culprits
Koumbi, L., Γιουλεμέ, Ό., & Vassilopoulou, Ε. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa176 · Cited by 21
“According to the Rome IV classification (20), IBS patients suffer from abdominal pain on average at least once a week for >6 mo before the diagnosis (5, 21).”
MethodDeb, C., Campion, S., Derrick, V., Ruiz, V., Abomoelak, B., Avdella, A., Zou, B., Horváth, K., & Mehta, D. I. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002852 · Cited by 24
“Similarly nausea and dyspepsia as presenting symptoms have also been reported in adults with lactase deficiency and SI deficiency (27,38,39).”
BackgroundA Combination of Mediterranean and Low-FODMAP Diets for Managing IBS Symptoms? Ask Your Gut!
Kasti, A. N., Petsis, K., Lambrinou, S., Katsas, K., Nikolaki, M. D., Papanikolaou, I. S., Hatziagelaki, E. E., & Τriantafyllou, Κ. (2022) · Microorganisms · doi:10.3390/microorganisms10040751 · Cited by 24
Chojnacki, C. J., Mędrek-Socha, M., Błońska, A., Zajdel, R., Chojnacki, J., & Popławski, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315314 · Cited by 22
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain
van Thiel, I. A. M., de Jonge, W., & van den Wijngaard, R. M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2168992 · Cited by 20
“Due to the lack of convincing biological indicators, IBS is diagnosed by the symptombased Rome IV criteria.(72) In search for alternative tools to discriminate patients with IBS from healthy individuals, or even identify patient subsets, numerous bacteria-focused microbiota analysis have been conducted on healthy volu…”
BackgroundUpdate on Pharmacotherapy for Irritable Bowel Syndrome
Munjal, A., Dedania, B. K., & Cash, B. D. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0692-7 · Cited by 22
Fecal markers in the management of inflammatory bowel disease
Dai, C., Jiang, M., & Sun, M. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1503919 · Cited by 19
“Rome criteria, have been developed but may be difficult to use in clinical practice [66].”
BackgroundAssociation between irritable bowel syndrome and asthma: a meta-analysis and systematic review
Deshmukh, F. (2019) · Annals of Gastroenterology · doi:10.20524/aog.2019.0426 · Cited by 24
“It affects mainly young patients (below the age of 50 years) and is one of the most common reasons for patients to be seen in outpatient gastroenterology clinics [3-5].”
BackgroundMethodInfluentialGut‐Directed Hypnotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis
Adler, E. C., Levine, E. H., Ibarra, A. N., Boparai, E. S., Hung, Y., McCrary, Q. D., & Lee, J. K. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70037 · Cited by 25
Jardon, K. M. C., Umanets, A., Gijbels, A., Trouwborst, I., Hul, G. B. J., Siebelink, E., Vliex, L. M. M., Bastings, J. J. A. J., Argamasilla, R., Chenal, E., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2501185 · Cited by 21
“41”
Connell, J., Toma, R., Ho, C. H.-C., Shen, N., Moura, P., Le, T., Patridge, E. V., Antoine, G., Keiser, H., Julian, C., et al. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231216393 · Cited by 21
Sieving out non-celiac gluten sensitivity amongst patients with irritable bowel syndrome
Ahmed, A., Dixit, K. K., Singh, A., Agarwal, A. K., Mehtab, W., Prasad, S., Rajput, M. S., Chauhan, A. K., Agarwal, A., Mehta, S., et al. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.10.014 · Cited by 19
Mokhtare, M., Karimi, S., Bahardoust, M., Sotoudeheian, M., Ghazi, A., & Babaei-Ghazani, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102495 · Cited by 19
Axelrod, L., Axelrod, S., Navalgund, A., & Triadafilopoulos, G. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06663-y · Cited by 13
Saadati, S., Sadeghi, A., Shalmani, H. M., Rostami‐Nejad, M., Elli, L., Asadzadeh‐Aghdaei, H., Rodrigo, L., & Zali, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-09055-6 · Cited by 27
Al‐Beltagi, M., Saeed, N. K., Bediwy, A. S., & Elbeltagi, R. M. (2025) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v14.i2.103323 · Cited by 39
Filippone, A., Ardizzone, A., Bova, V., Lanza, M., Casili, G., Cuzzocrea, S., Esposito, E., Campolo, M., & Paterniti, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11237073 · Cited by 16
Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review
Zhang, V. R., Ramachandran, G. K., Loo, E. X. L., Soh, A. Y. S., Yong, W. P., & Siah, K. T. H. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14536 · Cited by 17
Tavares, L. C., Lopera-Maya, E. A., Bonfiglio, F., Zheng, T., Sinha, T., Marques, F. Z., Zhernakova, A., Sanna, S., & D’Amato, M. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.04.002 · Cited by 19
Ghafar, M. Y. A., Yaakup, H., Ali, R. A. R., & Shah, S. A. (2020) · The journal of nutrition health & aging · doi:10.1007/s12603-020-1494-1 · Cited by 16
Löwe, B., Nestoriuc, Y., Andresen, V., Vettorazzi, E., Zapf, A., Hübener, S., Maehder, K., Peters, L., & Lohse, A. W. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059529 · Cited by 15
Du, L., Zhang, Z., Zhai, L., Xu, S., Yang, W., Huang, C., Lin, C., Zhong, L. L. D., Bian, Z., & Zhao, L. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00795-9 · Cited by 21
“Subject recruitment and pattern differentiation Adults (18–65 years) meeting the Rome IV criteria for IBS-D [20, 21] were recruited at Chinese medicine clinics affiliated with the School of Chinese Medicine, Hong Kong Baptist University.”
MethodFujihara, H., Matsunaga, M., Ueda, E., Kajiwara, T., Takeda, A., Watanabe, S., Baba, K., Hagihara, K., & Myowa, M. (2023) · Microorganisms · doi:10.3390/microorganisms11092245 · Cited by 18
“Following previous studies [43,44], we considered scores 1, 2, 6, and 7 as abnormal.”
Abid, S., Rehman, H., Awan, S., Artani, A., & Siddiqui, I. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268403 · Cited by 19
“The third installment, Rome III was published in 2006, and had some major changes compared to Rome II that came out in 1992 [6].”
ResultMitelmão, F. C. R., Häckel, K., Bergamaschi, C. D. C., Gerenutti, M., Silva, M. T., Balcão, V. M., & Vila, M. M. D. C. (2022) · Medicine · doi:10.1097/md.0000000000031185 · Cited by 19
“Constipation must have started 6 months earlier and become more frequent in the past 3 months, including 2 or more of the following characteristics: involving <25% of bowel movements (straining, hardened resistance - Bristol scale 1–2), feeling of incomplete evacuation, a sensation of anorectal obstruction, digital ma…”
BackgroundInfluentialMicroscopic Colitis: Pathogenesis and Diagnosis
Songtanin, B., Chen, J. N., & NUGENT, K. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134442 · Cited by 21
JanssenDuijghuijsen, L. M., van den Belt, M., Rijnaarts, I., Vos, A. P., Guillemet, D., Witteman, B. J. M., & de Wit, N. J. W. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03398-8 · Cited by 25
“/ AF / Probiotic BLa80) and time (observation [day 1 to 28] / intervention [day 29–56]) were included in the model as main effects and as interaction effect (time*treatment group), subject was included as random effect.”
InfluentialLinsalata, M., Ignazzi, A., D’Attoma, B., Riezzo, G., Mallardi, D., Orlando, A., Prospero, L., Notarnicola, M., Nunzio, V. D., Pinto, G., et al. (2024) · Nutrients · doi:10.3390/nu16162706 · Cited by 16
“According to the Rome IV diagnostic criteria, IBS can be categorized into four types: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), IBS with mixed bowel habits (IBS-M), and unclassified IBS (IBS-U) [2].”
MethodHakami, R. M., Elmakki, E. E., Hasanain, T., Alnami, A., Khawaji, A., Ali, L., Tobaigy, M. F., Allayl, A., Faqihi, I., Bajoned, M., et al. (2019) · Gastroenterology Insights · doi:10.4081/gi.2019.8239 · Cited by 15
“Then, responses were divided into: normal (0-7); borderline (8-10); and case (11-21).”
BackgroundSierżantowicz, R., Lewko, J., & Jurkowska, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17124230 · Cited by 20
Seger, S., Nasharuddin, N. N. B., Fernandez, S. L., Yunus, S. R. B. M., Shun, N. T. M., Agarwal, P., & Burud, I. A. S. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.37.151.21716 · Cited by 18
“This criterion has to be fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis [1].”
BackgroundDomingo, J. J. S. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.04.015 · Cited by 40
Mitelmão, F. C. R., Bergamaschi, C. D. C., Gerenutti, M., Hächel, K., Silva, M. T., Balcão, V. M., & Vila, M. M. D. C. (2021) · Medicine · doi:10.1097/md.0000000000024938 · Cited by 16
“Functional constipation is based on symptoms of [4] constipation severity.”
Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data
Lacy, B. E., Brenner, D. M., & Chey, W. D. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.040 · Cited by 14
Self-citationRinninella, E., Cintoni, M., Mele, M. C., & Gasbarrini, A. (2019) · Nutrients · doi:10.3390/nu11102499 · Cited by 14
“At least 40% of all the gastroenterological outpatient visits are due to functional gastrointestinal disorders (FGIDs), among which irritable bowel syndrome (IBS) is the most common, accounting for a worldwide prevalence of about 12% [1].”
BackgroundPitcher, C. K., Farmer, A. D., Haworth, J. J., Treadway, S., & Hobson, A. R. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07487-8 · Cited by 18
“Despite this high prevalence, diagnostic and treatment pathways remain sub-optimal and the majority of prescribed treatments are based on the alleviation of symptoms rather than addressing their underlying cause [5, 6].”
BackgroundTurmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence
Jafarzadeh, E., Shoeibi, S., Bahramvand, Y., Nasrollahi, E., Maghsoudi, A. S., Yazdi, F., Shayan, S. K., & Hassani, S. (2022) · Iranian Journal of Public Health · doi:10.18502/ijph.v51i6.9656 · Cited by 14
Liu, J., Lv, C., Wu, D., Wang, Y., Sun, C., Cheng, C., & Yu, Y. (2021) · Gastroenterology Research and Practice · doi:10.1155/2021/5491188 · Cited by 17
“According to Rome IV criteria [17, 19], there were 88 IBS-diarrhea patients, 35 IBS-constipation patients, and 3 IBS-mixed patients.”
MethodGrozić, A., Coker, K., Dussik, C. M., Sabir, M. S., Sabir, Z. L., Bradley, A., Zhang, L., Park, J. G., Yale, S. H., Kaneko, I., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275683 · Cited by 16
“The Rome IV criteria define IBS as abdominal pain with altered bowel habits as the predominant symptom at least once a week in the last 3 months [8].”
BackgroundMethodSoufan, F., Ghosson, A., Jaber, R. A., Ghandour, A., & Uwishema, O. (2025) · Health Science Reports · doi:10.1002/hsr2.70660 · Cited by 21
Food Sensitivity Testing and Elimination Diets in the Management of Irritable Bowel Syndrome
Cameron‐Smith, E., Foxx–Orenstein, A. E., Marks, L. A., & Agrwal, N. (2020) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2020.008 · Cited by 13
de Família, M., Oliveira, P. D. T. M., Reis, J. E. F., de Família, M., Reis, M. A. S., de Família, M., Ferreira, S. M. S., de Família, M., Candelária, A. L. A., & de Família, M. (2020) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v36i2.12545 · Cited by 18
Hypnotherapy and IBS: Implicit, long-term stress memory in the ENS?
Császár-Nagy, N., & Bókkon, I. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12751 · Cited by 22
“” According to the ROME III criteria in 2006, patients with IBS belong to one of the three predominant subtypes: IBS with constipation (IBS–C); IBS with diarrhoea (IBS-D); mixed IBS with alternating diarrhoea and constipation (IBS-M); and IBS-U is an unsubtyped IBS for people who do not fit into the IBS-D, IBS-C, and…”
MethodBuffone, F., Tarantino, A. G., Belloni, F., Spadafora, A., Bolzoni, G., Bruini, I., Bergna, A., & Vismara, L. (2023) · Healthcare · doi:10.3390/healthcare11172442 · Cited by 15
Biobehavioral approach to distinguishing panic symptoms from medical illness
Tunnell, N. C., Corner, S. E., Roque, A. D., Kroll, J. L., Ritz, T., & Meuret, A. E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1296569 · Cited by 22
“This contrasts with IBS, which is characterized by recurrent abdominal pain and changes in bowel habits, including diarrhea or constipation lasting for hours (198).”
BackgroundMethodGhodratı, A. D., & Çomoğlu, T. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400356 · Cited by 14
Global prevalence of constipation during pregnancy: a systematic review and meta-analysis
Salari, N., Mohamadi, S., Hemmati, M., Fallahi, A., Rasoulpoor, S., Zarei, H., Shohaimi, S., & Mohammadi, M. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-07057-y · Cited by 17
“I t i s u s e d t o c l a ss i f y , d i a g n o s e , a n d t r e a t g a s t r o i n t e s t i n a l ( G I ) d i s o r d e r s a n d i s r e v i s e d e v e r y f e w y e a r s [ 43 ] .”
Lin, H., Lv, Y., Liu, H., Zheng, L., Zhu, N., & Huang, B. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152058 · Cited by 15
Yang, C., Wu, M., Lin, M., & Wei, J. C. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100383 · Cited by 14
Okada, C., Kim, J. I., Melamed, M. L., Abraham, N., & Halani, P. K. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.12.007 · Cited by 13
Lee, S., Kim, C.-R., & Kim, K.-N. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.11.004 · Cited by 12
Alfaro-Cruz, L., Heitkemper, M. M., Chumpitazi, B. P., & Shulman, R. J. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001280 · Cited by 12
“trial 12 wk Yes Provided verbal and written material Yes (4) 8/188 (4) 8/188 (4) Not specified Method used to record adherence: Not specified Definition of adherence: Not specified % adhere:”
InfluentialA Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects
Moré, M. I., Postrach, E., Bothe, G., Heinritz, S. N., & Uebelhack, R. (2019) · Nutrients · doi:10.3390/nu12010064 · Cited by 12
Fatahi, S., Hosseini, A., Sohouli, M. H., Sayyari, A., Khatami, K., Farsani, Z. F., Amiri, H., Dara, N., de Souza, I. G. O., & Santos, H. O. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00516-6 · Cited by 16
“The Rome IV criteria are frequently used for the clinical diagnosis of IBS, involving recurrent abdominal pain on average at least 1 day/week in the last 3 months, associated with two or more of the following items: (1) related to defecation; (2) associated with a change in frequency of stool; and (3) associated with…”
MethodIrritable bowel syndrome following Clostridium difficile infection
Dayananda, P., & Wilcox, M. H. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000490 · Cited by 14
Prevalence of Irritable Bowel Syndrome in Saudi Arabia: A Systematic Review and Meta-Analysis
Almasary, M. H., Alkhalifah, K. M., Alotaibi, S. H., Elhefny, M., Alabssi, H., Alaklabi, S. S., Alayed, R. S., Alghamdi, A. A., & Albalawi, A. (2023) · Cureus · doi:10.7759/cureus.45357 · Cited by 19
“In general, comprehending the progression of diagnostic standards for IBS is crucial for healthcare professionals to diagnose and address this condition accurately [4].”
Update in diagnosis and management of irritable bowel syndrome
Hung, T., Wang, C.-Y., & Lee, H. (2023) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_104_23 · Cited by 24
“Before diagnosing IBS, it is crucial to thoroughly investigate warning signs [43].”
BackgroundHeidelbaugh, J. J., Hungin, A. P. S., Palsson, O. S., Anastasiou, F., Agréus, L., Fracasso, P., Maaroos, H., Matic, J. R., Mendive, J. M., Seifert, B., et al. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14967 · Cited by 12
Qin, D., Yue, L., Xue, B., Chen, M., Tang, T., & Zheng, H. (2019) · Medicine · doi:10.1097/md.0000000000015920 · Cited by 13
“It classify the form of human faeces into 7 categories: types 1 and 2 indicate constipation, with 4 being the ideal stools as they are easy to defecate while not containing excess liquid, 5 tending towards diarrhea, and 6 and 7 indicate diarrhea.([40])”
Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option
Saini, S., Narang, M., Srivastava, S., & Shah, D. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20679 · Cited by 13
Ahluwalia, B., Magnusson, M. K., Böhn, L., Störsrud, S., Larsson, F., Öhman, L., & Simrén, M. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211048133 · Cited by 11
Teige, E. S., Sortvik, U., & Lied, G. A. (2024) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s451675 · Cited by 12
Die Rolle Der Psychotherapie Beim Reizdarmsyndrom
Weibert, E., & Stengel, A. (2019) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-0829-6990 · Cited by 12
Persistent-postural perceptual dizziness (PPPD): Yes, it is a psychosomatic condition!
Hüfner, K., & Sperner‐Unterweger, B. (2019) · Journal of Vestibular Research · doi:10.3233/ves-190679 · Cited by 11
“:+4351250423691;Fax:+4351250424778;E-mail:katharina.huefner@tirol-kliniken.at. patients and internists deal with their psychosomatic bowel problems [2].”
Scrabbling the Nutraceutical Potential of Berries in Gastrointestinal Disorders: A Review
Rakha, A., Rasheed, H., Rabail, R., Muntaha, S. T., Fatima, I., Noreen, R., & Aadil, R. M. (2023) · Food Reviews International · doi:10.1080/87559129.2023.2224427 · Cited by 10
“[180] In current years, dietary management such as the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet has shown a promising role in IBS.”
BackgroundClinical application of transcranial magnetic stimulation for functional bowel disease
Li, G., Jin, B., & Fan, Z. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1213067 · Cited by 10
“Effectiveness of TMS for irritable bowel syndrome The Rome Commission has identified abdominal pain as a necessary condition for the diagnosis of IBS, and abdominal pain is often the main cause of distress in IBS patients (34).”
BackgroundLenoir, M., Wienke, J., Fardao-Beyler, F., & Roese, N. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10151-w · Cited by 10
Gholmie, Y., Lozinsky, A. C., Godwin, H., Reeve, K., Dzubiak, R., Shah, N., & Meyer, R. W. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12708 · Cited by 10
Wang, D., Li, Y., Shi, Y., & Hu, Z. (2022) · Chronobiology International · doi:10.1080/07420528.2022.2139713 · Cited by 15
“The current Rome criteria classify this group of diseases as functional gastrointestinal disorders (FGID) characterized by persistent and recurrent gastrointestinal symptoms (Barberio et al. 2021; Drossman 2016; Lacy and Patel 2017).”
BackgroundHeydari, P., Ghanadian, M., Asghari, G., Azimi, M., Babaeian, M., & Adibi, P. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.363599 · Cited by 11
“It is a nosological entity that affects women in their 30 to 39 and 50 to 59 (2).”
BackgroundNaseri, K., Dabiri, H., Olfatifar, M., Shahrbaf, M. A., Yadegar, A., Soheilian‐Khorzoghi, M., Sadeghi, A., Saadati, S., Rostami‐Nejad, M., Verma, A. K., et al. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02649-y · Cited by 16
“IBS is a functional gastrointestinal disorder that afflicts nearly 15% of the population worldwide, characterized by recurrent abdominal pain or discomfort, and changes in bowel habits, in the absence of any other disease to cause these symptoms [26, 27].”
BackgroundMethodSoussou, S., Jablaoui, A., Mariaule, V., Kriaa, A., Boudaya, H., Wysocka, M., Amouri, A., Gargouri, A. F., Lesner, A., Maguin, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44454-3 · Cited by 18
“After obtaining their consent, volunteers were subjected to clinical exams, including radiography and endoscopy and IBS was diagnosed conforming to the Rome IV criteria 3,10 .”
MethodOnișor, D. M., Brusnic, O., Bănescu, C. V., Claudia, C., Săsăran, M. O., Stoian, M., Avram, C., Boicean, A., Boeriu, A. M., & Dobru, D. E. (2024) · Biomedicines · doi:10.3390/biomedicines12061315 · Cited by 13
“IBS-D is defined according to the Rome IV criteria as being characterized by more than 25% of stools of low consistency (type 6 and 7 on the Bristol scale) and less than 25% of high consistency (type 1 and 2 on the Bristol scale) [10,11].”
BackgroundGentile, M., Luca, V. D., Patalano, R., Laudisio, D., Tramontano, G., Lindner, S., Mercurio, L., Salvatore, E., Farrell, J., Roller‐Wirnsberger, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.998838 · Cited by 11
“INCLUSION CRITHERIA were: (1) Age (18-70), (2) All gender, (3) No psychiatric illness under surveillance or treatment, (4) No previous proctological treatment, (5) No IBD, (6) No affiliation to other nutritional programme.”
BackgroundMethodThe Variability of Tryptophan Metabolism in Patients with Mixed Type of Irritable Bowel Syndrome
Chojnacki, J., Konrad, P., Mędrek-Socha, M., Kaczka, A., Błońska, A., Zajdel, R., Chojnacki, C. J., & Gąsiorowska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052550 · Cited by 11
“According to the Rome IV Criteria, four types of IBS are distinguished: that with predominant constipation (IBS-C), predominant diarrhea (IBS-D), mixed bowel habits (IBS-M) and unclassified type (IBS-U) [1].”
MethodFermented Vegetables as a Potential Treatment for Irritable Bowel Syndrome
Garnås, E. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.100039 · Cited by 11
Microbiota and probiotics: chances and challenges – a symposium report
Ruxton, C. H. S., Kajita, C., Rocca, P., & Pot, B. (2023) · Gut Microbiome · doi:10.1017/gmb.2023.4 · Cited by 12
“Bloating and pain are common symptoms (Lacy and Patel, 2017), often blamed on intestinal gas, but the symptoms could be due to heightened sensitivity to abdominal distention.”
BackgroundDiagnosis of Irritable Bowel Syndrome: Primary Care Physicians Compared with Gastroenterologists
Pareki, G., Wozniak, A. W., & Abegunde, A. T. (2023) · Clinical Medicine & Research · doi:10.3121/cmr.2023.1817 · Cited by 10
“2,10,11 The criteria for diagnosing IBS have undergone a series of revisions designed to make them more applicable across cultures and practice settings, and therefore more relevant to both patients and providers.”
BackgroundLluansí, A., Llirós, M., Carreras‐Torres, R., Bahí, A., Capdevila, M., Feliu, A., Vilà-Quintana, L., Masiques, N. E., Cueva, E., Peries, L., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297836 · Cited by 12
“According to the updated Rome IV criteria [3, 4], IBS has four subtypes: (i) IBS with constipation (IBS-C); (ii) IBS with diarrhea (IBS-D); (iii) mixed IBS (IBS-M); and (iv) unclassified IBS.”
Mechanism of Action Considerations in the Management of IBS-C.
Brenner, D. M. (2023) · PubMed Central · Cited by 10
A 5Ad Dietary Protocol for Functional Bowel Disorders
Ibrahim, F., & Stribling, P. (2019) · Nutrients · doi:10.3390/nu11081938 · Cited by 11
Enfrentamiento del paciente con dolor abdominal
Ugarte, M. J. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2021.06.005 · Cited by 9
Gut Feelings: The Microbiome and Our Health
Fasano, A., & Flaherty, S. (2021) · The MIT Press eBooks · doi:10.7551/mitpress/11291.001.0001 · Cited by 14
Metadata
- Authors
- Lacy, B., & Patel, N.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Corresponding author
- Patel, Nihal
- ORCID
- Lacy, Brian
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2017-10-26
- Volume
- 6
- Issue
- 11
- Pages
- 99
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5704116
- OpenAlex
- W2766963630
- Semantic Scholar
- b33dc825c1d24803a560443b65c3158fbf3991dd
- Cited by
- 575
- References
- 22
- Citations by year
- 2026: 46 · 2025: 72 · 2024: 85 · 2023: 104 · 2022: 74 · 2021: 79 · 2020: 58 · 2019: 43 · 2018: 14
- FWCI
- 33.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, Rome IV criteria, functional gastrointestinal disorders, IBS diagnosis, diagnostic criteria, abdominal pain, altered bowel habits, red flags, clinical history taking, cost-effective diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.